Literature DB >> 18353308

Rapid effects of 1alpha,25(OH)2D3 in resting human peripheral blood mononuclear cells.

Ingrid Lajdova1, Dusan Chorvat, Alzbeta Chorvatova.   

Abstract

The steroid hormone 1alpha,25(OH)2D3 produces biological responses via both genomic and nongenomic mechanisms. Stimulation of rapid, nongenomic responses by 1alpha,25(OH)2D3 has been postulated to result from interaction of the ligand with cell membrane 1alpha,25(OH)2D3 receptors and to involve membrane receptors. We examined the rapid effects of 1alpha,25(OH)2D3 on calcium mobilization and calcium entry into resting human peripheral blood mononuclear cells isolated from healthy volunteers. We also investigated the possible involvement of purinergic receptors in this action. 1alpha,25(OH)2D3 induced a time-dependent increase in intracellular calcium concentration ([Ca2+]i). The initial 1alpha,25(OH)2D3-stimulated calcium increment was sensitive to thapsigargin (Tg), indicating its origins in calcium release from intracellular stores. 2-Aminoethyldiphenyl borate (2APB), an inhibitor of capacitative calcium entry, caused a significant [Ca2+]i decrease in human cells treated with 1alpha,25(OH)2D3. Furthermore, in contrast to observations in osteoblasts and skeletal muscle cells, nifedipine had no effect on 1alpha,25(OH)2D3-induced calcium entry, suggesting that L-type calcium channels were not implicated in this action. Besides, 1alpha,25(OH)(2)D3 prevented the calcium entry induced by 3'-O-(4-benzoyl)benzoyl-adenosine 5'-triphosphate (BzATP), a specific agonist of purinergic P2X7 receptors. This finding was further confirmed by 1alpha,25(OH)2D3-induced reduction of BzATP- and 4-aminopyridine (4AP)-stimulated ethidium bromide fluorescence. The presented results demonstrate, for the first time in healthy, resting human peripheral blood mononuclear cells that 1alpha,25(OH)2D3 is capable of exerting a rapid, nongenomic effect on [Ca2+]i, while inhibiting of the P2X7 channel permeability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353308     DOI: 10.1016/j.ejphar.2008.02.004

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.

Authors:  Philip J Hughes; Ewa Marcinkowska; Elzbieta Gocek; George P Studzinski; Geoffrey Brown
Journal:  Leuk Res       Date:  2009-10-06       Impact factor: 3.156

2.  The Impact of Vitamin D3 Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease.

Authors:  Ingrid Lajdova; Viera Spustova; Adrian Oksa; Zuzana Kaderjakova; Dusan Chorvat; Marcela Morvova; Libusa Sikurova; Alzbeta Marcek Chorvatova
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

3.  Low serum 25-hydroxyvitamin D is associated with higher risk of frequent headache in middle-aged and older men.

Authors:  Jyrki K Virtanen; Rashid Giniatullin; Pekka Mäntyselkä; Sari Voutilainen; Tarja Nurmi; Jaakko Mursu; Jussi Kauhanen; Tomi-Pekka Tuomainen
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

4.  Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy.

Authors:  Francesca Lazzara; Anna Maria Longo; Giovanni Giurdanella; Gabriella Lupo; Chiara Bianca Maria Platania; Settimio Rossi; Filippo Drago; Carmelina Daniela Anfuso; Claudio Bucolo
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

5.  Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes.

Authors:  Francesca Silvagno; Enrico De Vivo; Angelo Attanasio; Valentina Gallo; Gianna Mazzucco; Gianpiero Pescarmona
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

6.  Potential role of hypovitaminosis D and Vitamin D supplementation during COVID-19 pandemic.

Authors:  Monica Verdoia; Giuseppe De Luca
Journal:  QJM       Date:  2020-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.